A detailed history of Genesee Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Genesee Capital Advisors, LLC holds 7,929 shares of MRK stock, worth $888,682. This represents 0.49% of its overall portfolio holdings.

Number of Shares
7,929
Previous 7,893 0.46%
Holding current value
$888,682
Previous $1.04 Million 5.76%
% of portfolio
0.49%
Previous 0.58%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$123.8 - $132.96 $4,456 - $4,786
36 Added 0.46%
7,929 $981,000
Q1 2024

Apr 22, 2024

SELL
$113.24 - $131.95 $8,493 - $9,896
-75 Reduced 0.94%
7,893 $1.04 Million
Q4 2023

Jan 29, 2024

BUY
$100.18 - $109.02 $76,637 - $83,400
765 Added 10.62%
7,968 $868,000
Q3 2023

Oct 24, 2023

SELL
$102.95 - $114.33 $21,001 - $23,323
-204 Reduced 2.75%
7,203 $741,000
Q2 2023

Jul 17, 2023

BUY
$108.61 - $118.38 $804,474 - $876,840
7,407 New
7,407 $854,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $284B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Genesee Capital Advisors, LLC Portfolio

Follow Genesee Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Genesee Capital Advisors, LLC with notifications on news.